83027-0156 NDC - VIREX (ADENOVIREN NOSODE, ASCLEPIAS TUBEROSA, CALCAREA ARSENICICA, CAMPHORA, COXSACKIE A2 NOSODE, COXSACKIE A3 NOSODE, COXSACKIE A4 NOSODE, COXSACKIE A5 NOSODE, COXSACKIE A7 NOSODE, COXSACKIE B1 NOSODE, COXSACKIE B3 NOSODE, COXSACKIE B4 NOSODE, COXSACKIE B5 NOSODE, CYTOMEGALOVIRUS NOSODE, ECHINACEA PURPUREA, EPSTEIN-BARR VIRUS NOSODE, EUPHRASIA OFFICINALIS, INFLUENZINUM, LAC VACCINUM, MORBILLINUM, NATRUM MURIATICUM, PHYTOLACCA DECANDRA, THUJA OCCIDENTALIS, TRIFOLIUM PRATENSE, VARIOLINUM)

Drug Information

  • Product NDC: 83027-0156
  • Proprietary Name: Virex
  • Non Proprietary Name: Adenoviren Nosode, Asclepias Tuberosa, Calcarea Arsenicica, Camphora, Coxsackie A2 Nosode, Coxsackie A3 Nosode, Coxsackie A4 Nosode, Coxsackie A5 Nosode, Coxsackie A7 Nosode, Coxsackie B1 Nosode, Coxsackie B3 Nosode, Coxsackie B4 Nosode, Coxsackie B5 Nosode, Cytomegalovirus Nosode, Echinacea Purpurea, Epstein-Barr Virus Nosode, Euphrasia Officinalis, Influenzinum, Lac Vaccinum, Morbillinum, Natrum Muriaticum, Phytolacca Decandra, Thuja Occidentalis, Trifolium Pratense, Variolinum
  • Active Ingredient(s): 3 [hp_X]/mL ASCLEPIAS TUBEROSA ROOT; 12 [hp_X]/mL CALCIUM ARSENATE; 12 [hp_X]/mL CAMPHOR (NATURAL); 6 [hp_X]/mL COW MILK; 3 [hp_X]/mL ECHINACEA PURPUREA WHOLE; 6 [hp_X]/mL EUPHRASIA STRICTA; 15 [hp_C]/mL HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; 9 [hp_C]/mL HUMAN COXSACKIEVIRUS A; 9 [hp_C]/mL HUMAN COXSACKIEVIRUS A2; 9 [hp_C]/mL HUMAN COXSACKIEVIRUS A7; 18 [hp_C]/mL HUMAN COXSACKIEVIRUS B; 9 [hp_C]/mL HUMAN COXSACKIEVIRUS B1; 9 [hp_C]/mL HUMAN COXSACKIEVIRUS B3; 9 [hp_C]/mL HUMAN COXSACKIEVIRUS B5; 15 [hp_C]/mL HUMAN HERPESVIRUS 4; 15 [hp_X]/mL HUMAN HERPESVIRUS 5; 12 [hp_C]/mL INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); 12 [hp_C]/mL INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); 12 [hp_C]/mL INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE; 12 [hp_C]/mL INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE; 16 [hp_X]/mL MEASLES VIRUS; 4 [hp_X]/mL PHYTOLACCA AMERICANA ROOT; 4 [hp_X]/mL SODIUM CHLORIDE; 6 [hp_X]/mL THUJA OCCIDENTALIS LEAFY TWIG; 3 [hp_X]/mL TRIFOLIUM PRATENSE FLOWER; 16 [hp_X]/mL VARIOLA VIRUS
  • Administration Route(s): ORAL
  • Dosage Form(s): SPRAY
  • Pharmacy Class(es): Actively Acquired Immunity [PE]; Allergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Live Human Adenovirus Type 4 Vaccine [EPC]; Milk Proteins [CS]; Non-Standardized Food Allergenic Extract [EPC]; Vaccines; Adenovirus [Chemical/Ingredient]; Vaccines; Live; Unattenuated [Chemical/Ingredient]

Labeler Information

Field Name Field Value
Labeler Name: Nutritional Specialties, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:10/3/2025

Package Information

No. Package Code Package Description Billing Unit
183027-0156-160 mL in 1 BOTTLE, SPRAY (83027-0156-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC83027-0156The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEVirexThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAdenoviren Nosode, Asclepias Tuberosa, Calcarea Arsenicica, Camphora, Coxsackie A2 Nosode, Coxsackie A3 Nosode, Coxsackie A4 Nosode, Coxsackie A5 Nosode, Coxsackie A7 Nosode, Coxsackie B1 Nosode, Coxsackie B3 Nosode, Coxsackie B4 Nosode, Coxsackie B5 Nosode, Cytomegalovirus Nosode, Echinacea Purpurea, Epstein-Barr Virus Nosode, Euphrasia Officinalis, Influenzinum, Lac Vaccinum, Morbillinum, Natrum Muriaticum, Phytolacca Decandra, Thuja Occidentalis, Trifolium Pratense, VariolinumThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESPRAYThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE10/3/2025This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMENutritional Specialties, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEASCLEPIAS TUBEROSA ROOT; CALCIUM ARSENATE; CAMPHOR (NATURAL); COW MILK; ECHINACEA PURPUREA WHOLE; EUPHRASIA STRICTA; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN COXSACKIEVIRUS A; HUMAN COXSACKIEVIRUS A2; HUMAN COXSACKIEVIRUS A7; HUMAN COXSACKIEVIRUS B; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B3; HUMAN COXSACKIEVIRUS B5; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE; MEASLES VIRUS; PHYTOLACCA AMERICANA ROOT; SODIUM CHLORIDE; THUJA OCCIDENTALIS LEAFY TWIG; TRIFOLIUM PRATENSE FLOWER; VARIOLA VIRUSAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH3; 12; 12; 6; 3; 6; 15; 9; 9; 9; 18; 9; 9; 9; 15; 15; 12; 12; 12; 12; 16; 4; 4; 6; 3; 16 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESActively Acquired Immunity [PE], Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/19/2025

Previous Code
Next Code